{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:53:24Z","timestamp":1784156004942,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["310295"],"award-info":[{"award-number":["310295"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101040247"],"award-info":[{"award-number":["101040247"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013114","name":"Broad Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013114","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.schres.2024.02.025","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:44:47Z","timestamp":1708713887000},"page":"118-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia"],"prefix":"10.1016","volume":"266","author":[{"given":"Ville","family":"M\u00e4kipelto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamari","family":"Tuulio-Henriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hakulinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solja","family":"Niemel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"L\u00e4hteenvuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asko","family":"Wegelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Kiesepp\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkki","family":"Isomets\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Kampman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisla","family":"Lahdensuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atiqul","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Suvisaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2024.02.025_bb0005","series-title":"Publications of the National Public Health Institute","article-title":"Health and functional capacity in Finland: baseline results of the health 2000 health examination survey","volume":"12","author":"Aromaa","year":"2004"},{"key":"10.1016\/j.schres.2024.02.025_bb0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00406-016-0711-8","article-title":"Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo","volume":"267","author":"Baandrup","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2024.02.025_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2024.02.025_bb0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hup.1017","article-title":"Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial","volume":"24","author":"Berk","year":"2009","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.02.025_bb0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/157340009788971137","article-title":"A review of modern antidepressants effects on neurocognitive function","volume":"5","author":"Biringer","year":"2009","journal-title":"Curr. Psychiatr. Rev."},{"key":"10.1016\/j.schres.2024.02.025_bb0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: a review and practical application","volume":"4","author":"Boustani","year":"2008","journal-title":"Aging Health"},{"key":"10.1016\/j.schres.2024.02.025_bb0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/schbul\/sbn135","article-title":"Psychiatric comorbidities and schizophrenia","volume":"35","author":"Buckley","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2024.02.025_bb0040","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2174\/1871527315666161003170312","article-title":"Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors improve cognitive function in partial responders depressed patients: results from a prospective observational cohort study","volume":"15","author":"Castellano","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.schres.2024.02.025_bb0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pnpbp.2010.11.006","article-title":"Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial","volume":"35","author":"Cho","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0050","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","article-title":"Anticholinergic drug exposure and the risk of dementia: a nested case-control study","volume":"179","author":"Coupland","year":"2019","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.schres.2024.02.025_bb0055","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/arclin\/acx120","article-title":"The residual medium and long-term cognitive effects of benzodiazepine use: an updated meta-analysis","volume":"33","author":"Crowe","year":"2018","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.schres.2024.02.025_bb0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.psychres.2008.05.012","article-title":"Screening for mood and anxiety disorders with the five-item, the three-item, and the two-item Mental Health Inventory","volume":"168","author":"Cuijpers","year":"2009","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2024.02.025_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000331141","article-title":"Does antidepressant treatment improve cognition in older people with schizophrenia or schizoaffective disorder and comorbid subsyndromal depression?","volume":"65","author":"Dawes","year":"2012","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2024.02.025_bb0070","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1037\/1064-1297.15.6.563","article-title":"Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine","volume":"15","author":"Delle Chiaie","year":"2017","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.02.025_bb0075","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/archpsyc.64.5.532","article-title":"Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia","volume":"64","author":"Dickinson","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0080","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neubiorev.2010.07.001","article-title":"The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis","volume":"35","author":"Fett","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2024.02.025_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-12-64","article-title":"Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence","volume":"12","author":"Fioravanti","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00406-017-0787-9","article-title":"Benzodiazepine long-term administration is associated with impaired attention\/working memory in schizophrenia: results from the national multicentre FACE-SZ data set","volume":"268","author":"Fond","year":"2018","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2024.02.025_bb0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4088\/JCP.15m10271","article-title":"Benzodiazepine use and risk of mortality among patients with schizophrenia: a retrospective longitudinal study","volume":"77","author":"Fontanella","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.jcp.0000161499.58266.51","article-title":"The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia","volume":"25","author":"Friedman","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.02.025_bb0105","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.schres.2017.03.002","article-title":"The relationship between level of cognitive impairment and functional outcome trajectories in first-episode schizophrenia","volume":"190","author":"Fu","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.02.025_bb0110","first-page":"1","article-title":"Anticholinergic burden and cognitive performance in patients with schizophrenia: a systematic literature review","volume":"12","author":"Georgiou","year":"2021","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2024.02.025_bb0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/13825585.2017.1294651","article-title":"Construct and concurrent validity of the Cambridge neuropsychological automated test in Portuguese older adults without neuropsychiatric diagnoses and with Alzheimer's disease dementia","volume":"25","author":"Gon\u00e7alves","year":"2016","journal-title":"Aging Neuropsychol. Cogn."},{"key":"10.1016\/j.schres.2024.02.025_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/627863","article-title":"Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction?","author":"Greer","year":"2014","journal-title":"Depress. Res. Treat."},{"key":"10.1016\/j.schres.2024.02.025_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-023-04552-y","article-title":"Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia","volume":"23","author":"Haddad","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0130","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00228-007-0349-6","article-title":"High concordance between self-reported medication and official prescription database information","volume":"63","author":"Haukka","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.schres.2024.02.025_bb0135","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/appi.ajp.2016.15081035","article-title":"Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis","volume":"173","author":"Helfer","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1370\/afm.2131","article-title":"Comparative associations between measures of anticholinergic burden and adverse clinical outcomes","volume":"15","author":"Hsu","year":"2017","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.schres.2024.02.025_bb0145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.eurpsy.2017.06.004","article-title":"Lifetime use of psychiatric medications and cognition at 43 years of age in schizophrenia in the Northern Finland Birth Cohort 1966","volume":"45","author":"Hulkko","year":"2017","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0150","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2024.02.025_bb0155","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1176\/appi.ajp.2020.20081212","article-title":"Anticholinergic medication burden\u2013associated cognitive impairment in schizophrenia","volume":"178","author":"Joshi","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4235\/jkgs.2009.13.2.69","article-title":"The usefulness of the Cambridge neuropsychological test automated battery (CANTAB) for assessing cognitive functions in the elderly: a pilot study","volume":"13","author":"Kim","year":"2009","journal-title":"J. Korean Geriatr. Soc."},{"key":"10.1016\/j.schres.2024.02.025_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2022-070710","article-title":"Cohort profile: SUPER-Finland, the Finnish study for hereditary mechanisms of psychotic disorder","volume":"13","author":"L\u00e4hteenvuo","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.schres.2024.02.025_bb0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.eurpsy.2006.11.004","article-title":"Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB","volume":"22","author":"Levaux","year":"2007","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0175","first-page":"701","article-title":"Augmentation with antidepressants in schizophrenia treatment: benefit or risk","volume":"11","author":"Mao","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2024.02.025_bb0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/YIC.0b013e32834bbc0d","article-title":"Duloxetine as adjunctive treatment to clozapine in patients with schizophrenia: a randomized, placebo-controlled trial","volume":"26","author":"Mic\u00f3","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.02.025_bb0185","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1080\/14640749108400962","article-title":"Reaction time analysis with outlier exclusion: bias varies with sample size","volume":"43","author":"Miller","year":"1991","journal-title":"Q. J. Exp. Psychol."},{"key":"10.1016\/j.schres.2024.02.025_bb0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1176\/appi.ajp.161.1.116","article-title":"Association of Anticholinergic Load with Impairment of complex attention and memory in schizophrenia","volume":"161","author":"Minzenberg","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0195","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/JCP.0b013e3182664cfc","article-title":"A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: a preliminary study","volume":"32","author":"Niitsu","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2024.02.025_bb0200","first-page":"113","article-title":"Benzodiazepines in schizophrenia. Is there a trend towards long-term prescribing?","volume":"24","author":"Paton","year":"2000","journal-title":"BJPsych Bull."},{"key":"10.1016\/j.schres.2024.02.025_bb0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0924-977X(02)00155-4","article-title":"Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study","volume":"13","author":"Poyurovsky","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2024.02.025_bb0210","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2022"},{"key":"10.1016\/j.schres.2024.02.025_bb0215","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann. Med."},{"key":"10.1016\/j.schres.2024.02.025_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/brb3.1962","article-title":"Generalized neurocognitive impairment in individuals at ultra-high risk for psychosis: the possible key role of slowed processing speed","volume":"11","author":"Randers","year":"2021","journal-title":"Brain Behav."},{"key":"10.1016\/j.schres.2024.02.025_bb0225","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2010.12.3\/areichenberg","article-title":"The assessment of neuropsychological functioning in schizophrenia","volume":"12","author":"Reichenberg","year":"2010","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.schres.2024.02.025_bb0230","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.schres.2019.11.018","article-title":"A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: time effects on neuropsychological performance and their relation to functional outcome","volume":"216","author":"Rodriguez-Toscano","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.02.025_bb0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/WNF.0000000000000442","article-title":"Long-term benzodiazepine prescription during maintenance therapy of individuals with psychosis Spectrum disorders\u2014associations with cognition and global functioning","volume":"44","author":"Savi\u0107","year":"2021","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.schres.2024.02.025_bb0240","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1017\/S0033291711002352","article-title":"Exploring the pattern and neural correlates of neuropsychological impairment in late-life depression","volume":"46","author":"Sexton","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2024.02.025_bb0245","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11065-018-9388-2","article-title":"Cognitive deficits in psychotic disorders: a lifespan perspective","volume":"28","author":"Sheffield","year":"2018","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.schres.2024.02.025_bb0250","doi-asserted-by":"crossref","DOI":"10.1017\/S1092852918001050","article-title":"Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder","volume":"24","author":"Solmi","year":"2019","journal-title":"CNS Spectr."},{"key":"10.1016\/j.schres.2024.02.025_bb0255","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.schres.2015.10.021","article-title":"Serum level of venlafaxine is associated with better memory in psychotic disorders","volume":"169","author":"Steen","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2024.02.025_bb0260","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S1461145709990897","article-title":"Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study","volume":"13","author":"Stenberg","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2024.02.025_bb0265","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.pnpbp.2011.03.004","article-title":"More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia","volume":"35","author":"Stenberg","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/schbul\/sbaa111","article-title":"Comparative effectiveness of antipsychotics for risk of attempted or completed suicide among persons with schizophrenia","volume":"47","author":"Taipale","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2024.02.025_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-13-115","article-title":"The predictive value of mental health for long-term sickness absence: the major depression inventory (MDI) and the mental health inventory (MHI-5) compared","volume":"13","author":"Thorsen","year":"2013","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.schres.2024.02.025_bb0280","first-page":"1","article-title":"Executive deficits in schizophrenia: mediation by processing speed and its relationship with aging","volume":"25","author":"Thuaire","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2024.02.025_bb0285","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/appi.ajp.2015.15050618","article-title":"Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: an observational follow-up study","volume":"173","author":"Tiihonen","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4236\/jbbs.2012.21013","article-title":"Clinical validation of Cambridge neuropsychological test automated battery in a norwegian epilepsy population","volume":"2","author":"Torgersen","year":"2012","journal-title":"J Behav. Brain Sci."},{"key":"10.1016\/j.schres.2024.02.025_bb0295","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1038\/s41380-020-00969-z","article-title":"Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings","volume":"26","author":"Velthorst","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2024.02.025_bb0300","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.schres.2014.08.015","article-title":"Antidepressants for cognitive impairment in schizophrenia \u2013 a systematic review and meta-analysis","volume":"159","author":"Vernon","year":"2014","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996424000616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996424000616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:56:24Z","timestamp":1760298984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996424000616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":60,"alternative-id":["S0920996424000616"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2024.02.025","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2024.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}